These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29640)

  • 1. The role of 2-keto-4-pentenoic acid in seizures induced by allylglycine.
    Horton RW
    Biochem Pharmacol; 1978 May; 27(10):1471-7. PubMed ID: 29640
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the effects of allylglycine and 2-keto-4-pentenoic acid on cerebral glutamic acid decarboxylase activity and convulsions in mice [proceedings].
    Horton RW; Meldrum BS
    Br J Pharmacol; 1977 Nov; 61(3):477P. PubMed ID: 588827
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of brain glutamate decarboxylase by 2-keto-4-pentenoic acid, a metabolite of allylglycine.
    Reingold DF; Orlowski M
    J Neurochem; 1979 Mar; 32(3):907-13. PubMed ID: 430066
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 4-methyl-2-methylenevalerate, a non-metabolizable analogue of 2-ketoisocaproate, on insulin secretion and metabolism in ob/ob mouse pancreatic islets.
    Lenzen S; Panten U
    Experientia; 1982 Sep; 38(9):1041-2. PubMed ID: 6751856
    [No Abstract]   [Full Text] [Related]  

  • 5. D-and L-stereoisomers of allylglycine: convulsive action and inhibition of brain L-glutamate decarboxylase.
    Orlowski M; Reingold DF; Stanley ME
    J Neurochem; 1977 Feb; 28(2):349-53. PubMed ID: 839217
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain and blood levels of allylglycine in mice following doses sufficient to inhibit glutamate decarboxylase.
    Taberner PV; Keen P
    J Neurochem; 1977 Sep; 29(3):595-7. PubMed ID: 894313
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo inactivation of gamma-aminobutyric acid-alpha-ketoglutarate transaminase by 4-amino-5-fluoropentanoic acid.
    Silverman RB; Levy MA; Muztar AJ; Hirsch JD
    Biochem Biophys Res Commun; 1981 Sep; 102(1):520-3. PubMed ID: 7306169
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioural effects of allylglycine (2-amino-4-pentenoic acid) and 2-keto-4-pentenoic acid following focal injection into the rat cerebellum and caudate nucleus [proceedings].
    Horton RW; Jenner P; Marsden CD; Meldrum BS; Reavill C
    Br J Pharmacol; 1978 Jun; 63(2):381P. PubMed ID: 667460
    [No Abstract]   [Full Text] [Related]  

  • 9. Enzyme-activated irreversible inhibition of rat and mouse brain 4-aminobutyric acid-alpha-ketoglutarate transaminase by 5-fluoro-4-oxo-pentanoic acid.
    Lippert B; Metcalf BW; Resvick RJ
    Biochem Biophys Res Commun; 1982 Sep; 108(1):146-52. PubMed ID: 7150278
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible inactivation of pig brain gamma-aminobutyric acid-alpha-ketoglutarate transaminase by 4-amino-5-halopentanoic acids.
    Silverman RB; Levy MA
    Biochem Biophys Res Commun; 1980 Jul; 95(1):250-5. PubMed ID: 7417253
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 4-pentenoic acid on lipids in plasma and liver of rats.
    Fujita T; Yasuda M
    Jpn J Pharmacol; 1975 Feb; 25(1):73-6. PubMed ID: 1152311
    [No Abstract]   [Full Text] [Related]  

  • 12. Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase.
    Horton RW; Meldrum BS
    Br J Pharmacol; 1973 Sep; 49(1):52-63. PubMed ID: 4207045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some properties of guinea pig brain glutamate decarboxylase and its inhibition by the convulsant allylglycine (2-amino-4-pentenoic acid).
    Fisher SK; Davies WE
    J Neurochem; 1974 Aug; 23(2):427-33. PubMed ID: 4153560
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of alpha-ketocarboxylic acids and 4-pentenoic acid on insulin secretion from the perfused rat pancreas.
    Lenzen S
    Biochem Pharmacol; 1978 May; 27(9):1321-4. PubMed ID: 697934
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of glycine synthase by branched-chain alpha-keto acids. A possible mechanism for abnormal glycine metabolism in ketotic hyperglycinemia.
    O'Brien WE
    Arch Biochem Biophys; 1978 Aug; 189(2):291-7. PubMed ID: 708054
    [No Abstract]   [Full Text] [Related]  

  • 16. Preconvulsive changes in brain glucose metabolism following drugs inhibiting glutamate decarboxylase.
    Horton RW; Meldrum BS
    J Neurochem; 1976 Apr; 26(4):805-9. PubMed ID: 965969
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of maple syrup urine disease metabolites on mouse L-fibroblasts in vitro: a fine structural and biochemical study.
    Bissell MG; Bensch KG; Herman MM
    J Neurochem; 1974 Jun; 22(6):957-64. PubMed ID: 4859303
    [No Abstract]   [Full Text] [Related]  

  • 18. Transmitter synthesis and convulsant drugs: effects of pyridoxal phosphate antagonists and allylglycine.
    Sawaya C; Horton R; Meldrum B
    Biochem Pharmacol; 1978 Feb; 27(4):475-81. PubMed ID: 24451
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of 4-pentenoic and pentanoic acids on the isolated rat atria.
    Varela A; Felip MN; Montesi A; Savino EA
    Arch Int Physiol Biochim; 1988 Dec; 96(5):165-70. PubMed ID: 2474276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of 5-(2-thienyl)valeric acid as a biotin antagonist.
    Izumi Y; Fukuda H; Tani Y; Ogata K
    Biochim Biophys Acta; 1977 Sep; 499(2):315-7. PubMed ID: 907790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.